This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Crown Castle (CCI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Crown Castle (CCI) closed the most recent trading day at $99.99, moving +0.22% from the previous trading session.
Crown Castle (CCI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Crown Castle (CCI) closed at $100.82, marking a +0.22% move from the previous day.
Crown Castle (CCI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Crown Castle (CCI) closed at $99.56, marking a +0.06% move from the previous day.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
OUTFRONT Media's (OUT) Q2 AFFO & Revenues Miss Estimates
by Zacks Equity Research
OUTFRONT Media's (OUT) Q2 results miss estimates. Higher operating expenses pose a concern. Nonetheless, a rise in billboard revenues and transit and other revenues aids the top line.
Equinix's (EQIX) Q2 AFFO Beats on Solid Demand, '23 View Up
by Zacks Equity Research
Equinix (EQIX) posts stellar Q2 results backed by strong demand for its colocation and interconnection services. It raises its AFFO per share guidance for 2023.
Boston Properties (BXP) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Boston Properties' (BXP) Q2 results outperform estimates on better-than-anticipated revenues, aided by healthy leasing activity. It has also raised its 2023 guidance for FFO per share.
SBA Communications' (SBAC) Q2 FFO & Revenues Beat, View Raised
by Zacks Equity Research
SBA Communications (SBAC) reports better-than-anticipated Q2 results on healthy leasing activity amid elevated tower space demand. It has also raised its outlook for 2023.
Digital Realty (DLR) Q2 FFO & Revenues Top, '23 View Revised
by Zacks Equity Research
Digital Realty's (DLR) Q2 earnings outshine estimates on higher revenues aided by solid rental revenue growth. The company revises its outlook for 2023.
Healthpeak's (PEAK) Q2 FFO & Revenues Beat, '23 View Revised
by Zacks Equity Research
Healthpeak's (PEAK) Q2 earnings outshine estimates on higher revenues. Same-store portfolio cash (adjusted) net operating income improves year over year. It revises its 2023 outlook.
American Tower (AMT) Q2 AFFO & Revenues Top, '23 View Revised
by Zacks Equity Research
American Tower's (AMT) Q2 results outshine estimates on higher revenues and strong organic tenant billing growth. It revises its outlook for 2023.
Crown Castle (CCI) Q2 AFFO & Revenues Beat, '23 View Revised
by Zacks Equity Research
Crown Castle's (CCI) Q2 results outshine estimates on better-than-anticipated revenues. However, it lowered its outlook for 2023, expecting a decline in tower activity for the remainder of the year.
Here's What Key Metrics Tell Us About Crown Castle (CCI) Q2 Earnings
by Zacks Equity Research
Although the revenue and EPS for Crown Castle (CCI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Crown Castle (CCI) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
Crown Castle (CCI) delivered FFO and revenue surprises of 3.02% and 0.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Prologis' (PLD) Q2 FFO Beats on Solid Rent Growth, '23 View Up
by Zacks Equity Research
Prologis' (PLD) second-quarter 2023 results reflect strong industrial real estate demand, leading to robust leasing activity and solid rent growth. It raises its core FFO per share outlook for 2023.
Why Crown Castle (CCI) Might Surprise This Earnings Season
by Zacks Equity Research
Crown Castle (CCI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Top Stocks Set to Beat Q2 Earnings Estimates This Month
by Nalak Das
We have narrowed our search to five companies that are set to declare second-quarter earnings results this month. These are: MMC, KNSL, RLI, BMI, CCI.
What's in the Cards for AGNC Investment's (AGNC) Q2 Earnings?
by Zacks Equity Research
High volatility, substantial spread widening and a notable increase in benchmark rates are expected to have affected AGNC Investment's (AGNC) Agency MBS performance and book value in Q2.
What's in Store for Crown Castle (CCI) This Earnings Season?
by Zacks Equity Research
Solid demand for wireless communication assets amid global 5G deployment efforts by wireless carriers is likely to have aided Crown Castle's (CCI) Q2 earnings. High interest rates might have hurt it.
Key Factors to Impact Prologis (PLD) This Earnings Season
by Zacks Equity Research
Prologis' (PLD) Q2 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though moderation in demand might partly limit the growth tempo.
Crown Castle (CCI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Crown Castle (CCI) closed at $115.37 in the latest trading session, marking a -0.92% move from the prior day.
Key Reasons to Add Crown Castle (CCI) to Your Portfolio Now
by Zacks Equity Research
The increase in demand for wireless communication assets amid rising data usage, strategic investments and a solid balance sheet present an optimistic near-term scenario for Crown Castle (CCI).
Prologis' (PLD) Shares Gain 11.1% YTD: Will the Trend Last?
by Zacks Equity Research
Healthy industrial real estate operating fundamentals, accretive acquisitions and solid balance sheet strength are likely to continue driving Prologis' (PLD) stock.
Wall Street Analysts Predict a 27.29% Upside in Crown Castle (CCI): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 27.3% upside potential for Crown Castle (CCI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Key Reasons to Add Welltower (WELL) to Your Portfolio Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens, strategic portfolio-repositioning efforts and a healthy balance sheet imply an optimistic near-term scenario for Welltower (WELL).